MICROZEN FORTE Tablet

គុណភាពព្យាបាល
ជាប្រភេទឱសថស្ថិតក្នុងក្រុម Anti inflammatory ប្រើសំរាប់៖
ការរលាកដោយវះកាត់ របួស រលាកស៊ីនុស(Sinus)រ៉ាំរ៉ៃនិងធ្ងន់ធ្ងរ ពេលវះកាត់ រលាកអញ្ចាញនៃថ្គាមទាល់ សាច់បំពង់ក អំបៅអំបែក ឈឺដោះ រលាកអញ្ចាញធ្មេញ អាប់សែបំពង់ខ្យល់ វះកាត់ទ្វារមាស(ពេលសំរាលកូន) រហែកperineal រលាកដៃស្បូន រលាកប្លោកនោម រលាកបំពង់ទឹកមូត្រ រលាកទងសួត របេងសួត ជម្ងឺហឺតសួត ក្រោយប្រើថ្នាំសណ្ដំ។
កំរិតនិងរបៀបប្រើ
លេបទាំងមូល ម្ដង1/2 គ្រាប់ ទៅ1គ្រាប់ 1ថ្ងៃ3ដង ក្រោយអាហារ អាស្រ័យតាមអាយុ។

For the following conditions:

Inflammation associated with surgery, trauma, acute and chronic sinusitis, tonsillectomy, otitis media; breast engorgement; periodontitis, alveolar abscess, pericoronitis of wisdom tooth; lateral episiotomy, perineal laceration, salpingitis, cystitis, epididymitis, urethritis; incomplete expectoration of sputum in bronchitis, pulmonary tuberculosis, bronchial asthma, after anaesthesia.

Serratiopeptidase is widely used in a variety of lung conditions.

Dosage and administration

The recommended dose is 5-10mg three times a day depending on the age.

The tablets are enteric coated and should be swallowed whole after a meal.

ហាមប្រើចំពោះអ្នកងាយមានប្រតិកម្មជាមួយសារធាតុផ្សំណាមួយនៃឱសថនេះ។

There are no known contraindications to Serratiopeptidase.

ផលរំខានខ្លះៗមាន វិបត្តិក្រពះ ពោះវៀន ដូចជា មិនឃ្លានអាហារ ចង្អោរ។

Generally, Serratiopeptidase is well tolerated. Occasionally it may cause gastro-intestinal effects such as anorexia, gastric discomfort and nausea.

Hypersensitivity reactions may occur rarely.

No drug interactions have been reported nor are there any reports of interference with any diagnostic tests.

ការប្រុងប្រយ័ត្នចំពោះ៖
- អ្នកជម្ងឺមានកំណកឈាមមិនប្រក្រតី
- អ្នកជម្ងឺខូចតម្រងនោម និងថ្លើមធ្ងន់ធ្ងរ
- អ្នកជម្ងឺកំពុងព្យាបាលដោយឱសថប្រឆាំងឈាមកក (Anticoagulants)។

Serratiopeptidase should be given with caution to patients with coagulation abnormalities, severe hepatic or renal impairment, or those under treatment with anticoagulants. Patients should be under careful observation.

A protease with anti-inflammatory activity.

Serratiopeptidase improves aggravated circulation in the inflammatory focus by breaking down abnormal exudates and protein and by promoting the absorption of the decomposed products through the blood and lymphatic vessels. It also accelerates the elimination of sputum, pus and haematoma by breaking down the liquefying mucus secretions and fibrin clots. Another major useful action being increased concentration of antibiotics in the focus of infection.